Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatitis | 3 | 2026 | 22 | 2.610 |
Why?
|
| Education, Medical | 3 | 2026 | 293 | 1.960 |
Why?
|
| Bacterial Infections | 2 | 2026 | 327 | 1.510 |
Why?
|
| Urinary Tract Infections | 3 | 2026 | 342 | 1.450 |
Why?
|
| Artificial Intelligence | 2 | 2026 | 369 | 1.210 |
Why?
|
| Internship and Residency | 3 | 2023 | 1223 | 1.120 |
Why?
|
| Hand Hygiene | 1 | 2025 | 18 | 0.910 |
Why?
|
| Nurses | 1 | 2025 | 65 | 0.870 |
Why?
|
| Problem-Based Learning | 1 | 2025 | 81 | 0.840 |
Why?
|
| Urinary Catheters | 1 | 2024 | 26 | 0.810 |
Why?
|
| Teaching Rounds | 1 | 2023 | 30 | 0.770 |
Why?
|
| Congresses as Topic | 1 | 2024 | 184 | 0.750 |
Why?
|
| Guideline Adherence | 1 | 2025 | 387 | 0.750 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2023 | 88 | 0.740 |
Why?
|
| Catheter-Related Infections | 1 | 2024 | 146 | 0.710 |
Why?
|
| Education, Medical, Graduate | 2 | 2023 | 554 | 0.660 |
Why?
|
| Communicable Diseases | 1 | 2023 | 155 | 0.650 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 223 | 0.600 |
Why?
|
| Anti-Bacterial Agents | 3 | 2026 | 2596 | 0.600 |
Why?
|
| Cyclonic Storms | 2 | 2017 | 82 | 0.590 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 208 | 0.590 |
Why?
|
| Containment of Biohazards | 1 | 2018 | 4 | 0.570 |
Why?
|
| Physicians | 1 | 2025 | 635 | 0.570 |
Why?
|
| Lassa virus | 1 | 2018 | 25 | 0.560 |
Why?
|
| Lassa Fever | 1 | 2018 | 14 | 0.560 |
Why?
|
| Contact Tracing | 1 | 2018 | 61 | 0.540 |
Why?
|
| Students, Medical | 1 | 2022 | 347 | 0.540 |
Why?
|
| Travel | 1 | 2018 | 117 | 0.530 |
Why?
|
| Chronic Disease | 4 | 2026 | 1246 | 0.500 |
Why?
|
| Thrombosis | 1 | 2021 | 499 | 0.490 |
Why?
|
| Fumigation | 1 | 2015 | 1 | 0.460 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2015 | 5 | 0.460 |
Why?
|
| Housing | 1 | 2015 | 74 | 0.440 |
Why?
|
| Humans | 33 | 2026 | 131163 | 0.440 |
Why?
|
| Curriculum | 3 | 2025 | 798 | 0.400 |
Why?
|
| Infection Control | 2 | 2025 | 158 | 0.390 |
Why?
|
| Psychometrics | 1 | 2017 | 678 | 0.390 |
Why?
|
| Aging | 1 | 2020 | 1242 | 0.390 |
Why?
|
| Acute Disease | 2 | 2026 | 1153 | 0.380 |
Why?
|
| New Jersey | 5 | 2018 | 28 | 0.370 |
Why?
|
| Environmental Exposure | 1 | 2015 | 298 | 0.360 |
Why?
|
| Male | 14 | 2026 | 64957 | 0.280 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 4066 | 0.260 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 3061 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2004 | 32 | 0.250 |
Why?
|
| Cardiology | 2 | 2022 | 514 | 0.250 |
Why?
|
| Tuberculosis | 2 | 2024 | 550 | 0.240 |
Why?
|
| Pandemics | 2 | 2023 | 1118 | 0.230 |
Why?
|
| Pneumonia, Bacterial | 1 | 2026 | 78 | 0.220 |
Why?
|
| Aged | 9 | 2026 | 21025 | 0.210 |
Why?
|
| Cyclins | 2 | 2004 | 94 | 0.210 |
Why?
|
| RNA Polymerase II | 2 | 2004 | 83 | 0.210 |
Why?
|
| Cell Size | 1 | 2004 | 77 | 0.200 |
Why?
|
| Latent Tuberculosis | 1 | 2024 | 75 | 0.200 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2024 | 91 | 0.200 |
Why?
|
| Urinary Catheterization | 1 | 2024 | 72 | 0.200 |
Why?
|
| Consultants | 1 | 2023 | 13 | 0.200 |
Why?
|
| Cardiomegaly | 1 | 2004 | 117 | 0.190 |
Why?
|
| Hospitals | 1 | 2025 | 435 | 0.190 |
Why?
|
| Blood Culture | 1 | 2023 | 44 | 0.180 |
Why?
|
| BK Virus | 1 | 2023 | 58 | 0.180 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 105 | 0.180 |
Why?
|
| Self Report | 1 | 2025 | 554 | 0.180 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2022 | 11 | 0.180 |
Why?
|
| Nephritis, Interstitial | 1 | 2023 | 41 | 0.180 |
Why?
|
| Internal Medicine | 1 | 2023 | 124 | 0.180 |
Why?
|
| Cross Infection | 1 | 2025 | 339 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 87 | 0.180 |
Why?
|
| Bacteria | 1 | 2026 | 521 | 0.180 |
Why?
|
| Teaching | 1 | 2023 | 196 | 0.170 |
Why?
|
| Adult | 7 | 2025 | 31282 | 0.170 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 88 | 0.170 |
Why?
|
| Shock, Septic | 1 | 2022 | 150 | 0.160 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 707 | 0.150 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 32 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2023 | 564 | 0.150 |
Why?
|
| Liberia | 1 | 2018 | 9 | 0.140 |
Why?
|
| Murinae | 1 | 2018 | 10 | 0.140 |
Why?
|
| Inpatients | 1 | 2023 | 562 | 0.140 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 36 | 0.140 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 345 | 0.140 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 43 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2018 | 352 | 0.130 |
Why?
|
| Female | 9 | 2025 | 70963 | 0.130 |
Why?
|
| Meningitis, Meningococcal | 1 | 2017 | 14 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 558 | 0.130 |
Why?
|
| Neisseria meningitidis, Serogroup B | 1 | 2017 | 7 | 0.130 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 51 | 0.130 |
Why?
|
| Meningococcal Vaccines | 1 | 2017 | 30 | 0.130 |
Why?
|
| Middle Aged | 7 | 2024 | 28601 | 0.130 |
Why?
|
| Cognition | 1 | 2022 | 829 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 128 | 0.120 |
Why?
|
| Universities | 1 | 2017 | 125 | 0.120 |
Why?
|
| Adolescent | 4 | 2020 | 20987 | 0.120 |
Why?
|
| United States | 4 | 2025 | 12072 | 0.120 |
Why?
|
| Disasters | 1 | 2017 | 101 | 0.120 |
Why?
|
| Heart Transplantation | 1 | 2023 | 800 | 0.120 |
Why?
|
| Vaccination | 1 | 2021 | 1060 | 0.120 |
Why?
|
| United States Virgin Islands | 1 | 2015 | 2 | 0.110 |
Why?
|
| Young Adult | 3 | 2020 | 10103 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 430 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2022 | 1050 | 0.110 |
Why?
|
| Public Health | 1 | 2017 | 269 | 0.110 |
Why?
|
| Feces | 1 | 2018 | 721 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 506 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 999 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 414 | 0.100 |
Why?
|
| Macrolides | 1 | 2013 | 31 | 0.100 |
Why?
|
| Advisory Committees | 2 | 2022 | 150 | 0.090 |
Why?
|
| Necrosis | 1 | 2011 | 192 | 0.080 |
Why?
|
| American Heart Association | 2 | 2022 | 343 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 3016 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1545 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 389 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2024 | 17753 | 0.070 |
Why?
|
| Bacteremia | 1 | 2011 | 446 | 0.060 |
Why?
|
| Cyclin T | 2 | 2004 | 31 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 744 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2018 | 311 | 0.060 |
Why?
|
| Risk Factors | 2 | 2017 | 11074 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2020 | 15110 | 0.050 |
Why?
|
| Community-Acquired Infections | 1 | 2026 | 254 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 82 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 65 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 279 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 33912 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 279 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2004 | 1571 | 0.040 |
Why?
|
| Child | 1 | 2020 | 26341 | 0.040 |
Why?
|
| Myocardium | 1 | 2004 | 852 | 0.040 |
Why?
|
| Incidence | 2 | 2019 | 3360 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2022 | 514 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 321 | 0.030 |
Why?
|
| Death Certificates | 1 | 2017 | 10 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 650 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2022 | 1064 | 0.030 |
Why?
|
| Leukemia | 1 | 2019 | 387 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1282 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 315 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 263 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 319 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 2406 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1882 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1950 | 0.020 |
Why?
|
| Serotyping | 1 | 2011 | 170 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 197 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2004 | 4686 | 0.020 |
Why?
|
| Heart Failure | 1 | 2004 | 2332 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 144 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3686 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1280 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 905 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 477 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6797 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 2114 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2825 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 887 | 0.010 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2004 | 5 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2004 | 6 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2004 | 8 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12936 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2065 | 0.010 |
Why?
|
| Lung | 1 | 2011 | 1535 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 576 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 697 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1207 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1481 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1363 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 668 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2885 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3370 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1827 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1939 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 18301 | 0.000 |
Why?
|